Voxilaprevir
id:
voxilaprevir-289-3100666
title:
Voxilaprevir
text:
Voxilaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir. The combination has the trade name Vosevi and received a positive opinion from the European Committee for Medicinal Products for Human Use in June 2017. On 18 July 2017, Vosevi was approved by the US Food and Drug Administration.
brand slug:
wiki
category slug:
encyclopedia
description:
Protease inhibitor
original url:
https://en.wikipedia.org/wiki/Voxilaprevir
date created:
date modified:
2023-01-28T16:37:27Z
main entity:
{"identifier":"Q27236086","url":"https://www.wikidata.org/entity/Q27236086"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/ba/Voxilaprevir.svg","width":512,"height":478}
fields total:
13
integrity:
15